Am Fam Physician. 2022;106(6):online
Author disclosure: No relevant financial relationships.
Details for This Review
Study Population: People two to 21 years of age with autism spectrum disorder (ASD) defined in the Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5) or the International Classification of Diseases, 11th ed. (ICD-11). More than one-half of the studies were conducted in North America or Asia. Most participants were males between two and 12 years of age. The studies included people with a range of mild to severe autism.1
Efficacy End Points: Global autism improvement, social interactions, nonverbal communication, verbal communication, quality of life, total autism symptom severity
Harm End Points: Hospitalization, other institutional stays, and adverse events reported by parents
| Benefits | Harms |
|---|---|
| 1 in 11 autistic people at low risk and 1 in 6 at high risk demonstrated global autism improvement after receiving music therapy | No adverse events were reported for the study intervention |
Subscribe
From $165- Immediate, unlimited access to all AFP content
- More than 130 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available
